CN112972284A - 一种用于眼部护理的多肽组合物及应用 - Google Patents
一种用于眼部护理的多肽组合物及应用 Download PDFInfo
- Publication number
- CN112972284A CN112972284A CN202110244468.5A CN202110244468A CN112972284A CN 112972284 A CN112972284 A CN 112972284A CN 202110244468 A CN202110244468 A CN 202110244468A CN 112972284 A CN112972284 A CN 112972284A
- Authority
- CN
- China
- Prior art keywords
- composition
- eye
- tetrapeptide
- acetyl
- eye care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 229920001184 polypeptide Polymers 0.000 title abstract description 11
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract description 11
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract description 11
- ROTFCACGLKOUGI-JYJNAYRXSA-N (2s)-2-[[(2s)-2-[[(2s)-2-(3-acetamidopropanoylamino)-3-(1h-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1h-imidazol-5-yl)propanoic acid Chemical compound C([C@H](NC(=O)CCNC(=O)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 ROTFCACGLKOUGI-JYJNAYRXSA-N 0.000 claims abstract description 22
- IHRKJQSLKLYWBQ-QKDODKLFSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O IHRKJQSLKLYWBQ-QKDODKLFSA-N 0.000 claims abstract description 19
- 229940094946 palmitoyl tetrapeptide-7 Drugs 0.000 claims abstract description 19
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims abstract description 18
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims abstract description 18
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 claims abstract description 18
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims abstract description 18
- 239000002537 cosmetic Substances 0.000 claims abstract description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 54
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 54
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 238000003756 stirring Methods 0.000 claims description 27
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 18
- 239000004359 castor oil Substances 0.000 claims description 18
- 235000019438 castor oil Nutrition 0.000 claims description 18
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000008213 purified water Substances 0.000 claims description 9
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 2
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 2
- 229940035437 1,3-propanediol Drugs 0.000 claims description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 2
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 claims 1
- 238000010979 pH adjustment Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 230000009471 action Effects 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 230000007246 mechanism Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000000474 nursing effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 25
- 239000000686 essence Substances 0.000 description 14
- 239000002253 acid Substances 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 238000004806 packaging method and process Methods 0.000 description 8
- 239000003513 alkali Substances 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 230000037303 wrinkles Effects 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 210000000744 eyelid Anatomy 0.000 description 4
- 235000002673 Dioscorea communis Nutrition 0.000 description 3
- 241000544230 Dioscorea communis Species 0.000 description 3
- 208000035753 Periorbital contusion Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 238000005562 fading Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 102000000583 SNARE Proteins Human genes 0.000 description 1
- 108010041948 SNARE Proteins Proteins 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 102000004183 Synaptosomal-Associated Protein 25 Human genes 0.000 description 1
- 108010057722 Synaptosomal-Associated Protein 25 Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- -1 caprylyl hydroxamic Chemical compound 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001739 rebound effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
组分名称 | 含量百分比 |
三肽-1 | 0.05-2% |
棕榈酰四肽-7 | 0.05-2% |
乙酰基六肽-8 | 0.05-2% |
乙酰基四肽-5 | 0.05-2% |
甘油 | 1.0-10% |
丙二醇 | 1.0-10% |
PEG氢化蓖麻油 | 0.1-5% |
PHL | 0.5-1.0% |
醋酸 | 0-1% |
三乙醇胺 | 0-1% |
纯化水 | 余量 |
组分名称 | 含量百分比 |
三肽-1 | 1.0% |
棕榈酰四肽-7 | 1.0% |
乙酰基六肽-8 | 1.0% |
乙酰基四肽-5 | 1.0% |
甘油 | 5.0% |
丙二醇 | 5.0% |
PEG氢化蓖麻油 | 2.5% |
PHL | 0.75% |
醋酸 | 0.5% |
三乙醇胺 | 0.5% |
纯化水 | 余量 |
组分名称 | 含量百分比 |
三肽-1 | 0.05% |
棕榈酰四肽-7 | 2.0% |
乙酰基六肽-8 | 0.05% |
乙酰基四肽-5 | 2.0% |
甘油 | 1.0% |
丙二醇 | 10.0% |
PEG氢化蓖麻油 | 5.0% |
PHL | 0.5% |
醋酸 | 0% |
三乙醇胺 | 1.0% |
纯化水 | 余量 |
组分名称 | 含量百分比 |
三肽-1 | 2.0% |
棕榈酰四肽-7 | 0.05% |
乙酰基六肽-8 | 2.0% |
乙酰基四肽-5 | 0.05% |
甘油 | 10.0% |
丙二醇 | 1.0% |
PEG氢化蓖麻油 | 0.1% |
PHL | 1.0% |
醋酸 | 1.0% |
三乙醇胺 | 0% |
纯化水 | 余量 |
组分名称 | 含量百分比 |
三肽-1 | 1.0% |
棕榈酰四肽-7 | 1.0% |
乙酰基六肽-8 | 1.0% |
乙酰基四肽-5 | 1.0% |
甘油 | 5.0% |
丙二醇 | 5.0% |
PEG氢化蓖麻油 | 2.5% |
PHL | 0.75% |
醋酸 | 0.5% |
三乙醇胺 | 0.5% |
纯化水 | 余量 |
组分名称 | 含量百分比 |
三肽-1 | 2.0% |
乙酰基四肽-5 | 2.0% |
甘油 | 5.0% |
丙二醇 | 5.0% |
PEG氢化蓖麻油 | 2.5% |
PHL | 0.75% |
醋酸 | 0.5% |
三乙醇胺 | 0.5% |
纯化水 | 余量 |
组分名称 | 含量百分比 |
棕榈酰四肽-7 | 2.0% |
乙酰基四肽-5 | 2.0% |
甘油 | 5.0% |
丙二醇 | 5.0% |
PEG氢化蓖麻油 | 2.5% |
PHL | 0.75% |
醋酸 | 0.5% |
三乙醇胺 | 0.5% |
纯化水 | 余量 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110244468.5A CN112972284A (zh) | 2021-03-05 | 2021-03-05 | 一种用于眼部护理的多肽组合物及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110244468.5A CN112972284A (zh) | 2021-03-05 | 2021-03-05 | 一种用于眼部护理的多肽组合物及应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112972284A true CN112972284A (zh) | 2021-06-18 |
Family
ID=76352994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110244468.5A Pending CN112972284A (zh) | 2021-03-05 | 2021-03-05 | 一种用于眼部护理的多肽组合物及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112972284A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115363986A (zh) * | 2022-09-29 | 2022-11-22 | 广东丸美生物技术股份有限公司 | 具有改善黑眼圈作用的护肤组合物及其制备方法和化妆品 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108338934A (zh) * | 2017-01-23 | 2018-07-31 | 珠海联邦制药股份有限公司 | 一种用于眼部护理的多肽组合物及其应用 |
CN109106607A (zh) * | 2018-07-12 | 2019-01-01 | 上海典雅生物科技有限公司 | 一种含有保湿因子和草本植物精华的精华素 |
CN109602632A (zh) * | 2019-01-23 | 2019-04-12 | 广州葆妍生物科技有限公司 | 一种含肽类组合物的眼霜及其制备方法 |
CN110538093A (zh) * | 2019-10-17 | 2019-12-06 | 广州丽彦妆生物科技有限公司 | 一种多肽修复液及其制备方法 |
CN111035609A (zh) * | 2020-01-10 | 2020-04-21 | 上海赵小蝶化妆品有限公司 | 一种小分子多肽眼部精华及其制备方法 |
CN111110599A (zh) * | 2019-12-27 | 2020-05-08 | 皓雨(广州)化妆品制造有限公司 | 一种透明卸妆膏及其制备方法、双头产品 |
CN111956531A (zh) * | 2020-09-11 | 2020-11-20 | 浙江英树生物科技有限公司 | 一种多重活性肽紧致抗衰组合物及其制备方法和应用 |
-
2021
- 2021-03-05 CN CN202110244468.5A patent/CN112972284A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108338934A (zh) * | 2017-01-23 | 2018-07-31 | 珠海联邦制药股份有限公司 | 一种用于眼部护理的多肽组合物及其应用 |
CN109106607A (zh) * | 2018-07-12 | 2019-01-01 | 上海典雅生物科技有限公司 | 一种含有保湿因子和草本植物精华的精华素 |
CN109602632A (zh) * | 2019-01-23 | 2019-04-12 | 广州葆妍生物科技有限公司 | 一种含肽类组合物的眼霜及其制备方法 |
CN110538093A (zh) * | 2019-10-17 | 2019-12-06 | 广州丽彦妆生物科技有限公司 | 一种多肽修复液及其制备方法 |
CN111110599A (zh) * | 2019-12-27 | 2020-05-08 | 皓雨(广州)化妆品制造有限公司 | 一种透明卸妆膏及其制备方法、双头产品 |
CN111035609A (zh) * | 2020-01-10 | 2020-04-21 | 上海赵小蝶化妆品有限公司 | 一种小分子多肽眼部精华及其制备方法 |
CN111956531A (zh) * | 2020-09-11 | 2020-11-20 | 浙江英树生物科技有限公司 | 一种多重活性肽紧致抗衰组合物及其制备方法和应用 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115363986A (zh) * | 2022-09-29 | 2022-11-22 | 广东丸美生物技术股份有限公司 | 具有改善黑眼圈作用的护肤组合物及其制备方法和化妆品 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103505377B (zh) | 一种具皮肤活性的多肽组合物 | |
JPH1029929A (ja) | 目の下の皮膚のくすみをとるための合成物と方法 | |
CN105287340B (zh) | 一种美白保湿眼霜及其制备方法 | |
CN111686048B (zh) | 一种抗衰老精华及其制备方法 | |
EP3552598A1 (en) | Composition containing crocus sativus extract and preparation method and use thereof | |
CN112972284A (zh) | 一种用于眼部护理的多肽组合物及应用 | |
CN112716826B (zh) | 一种长效祛皱和提升皮肤弹性的多肽组合物 | |
KR102054793B1 (ko) | 천연물추출물과 발효추출물을 함유하는 피부탄력개선 및 다크서클완화용 항산화 화장품 조성물 및 그 제조방법 | |
CN109157449B (zh) | 抗衰老保湿精华液及其制备工艺 | |
CN114642614A (zh) | 含有灵芝茯苓的组合物及其应用 | |
KR20120017987A (ko) | 눈가 주름 개선용 화장료 조성물 | |
CN113876661A (zh) | 眼部抗衰组合物及其应用 | |
CN110711150B (zh) | 一种多肽脂质体的制备方法及其应用 | |
KR102559639B1 (ko) | 샴푸 조성물 및 이의 제조방법 | |
CN110151567B (zh) | 一种水通道蛋白补水修复面膜及其制备方法 | |
CN116869898A (zh) | 增强屏障的敏感皮肤用修护霜及其制备方法 | |
CN110859758A (zh) | 一种美白抗衰老修复型医用冷敷贴及其制备方法 | |
CN114159341B (zh) | 一种冻干眼贴及其制备方法 | |
CN108371646B (zh) | 一种化妆品组合物及其应用 | |
CN110613623A (zh) | 一种小分子鞣花酸溶液的制备方法 | |
CN110251442A (zh) | 细胞修复精华液 | |
CN113786361B (zh) | 一种具有祛眼袋功效的眼霜组合物及其制备方法 | |
CN113350208A (zh) | 具备生发、保湿、增强头皮免疫力功效的冻干粉及其制备方法 | |
CN111096914A (zh) | 一种大麻叶净颜平衡面膜及其制作方法 | |
CN111514060B (zh) | 一种具有保湿抗衰功效的粉底液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230301 Address after: 272000 No.1 packaging workshop of electronic standard workshop, No.10 Industrial Park, high tech Zone, Jining City, Shandong Province Applicant after: Shandong kesidamei Biotechnology Co.,Ltd. Applicant after: BLOOMAGE BIOTECH Co.,Ltd. Address before: 272000 No.1 packaging workshop of electronic standard workshop, No.10 Industrial Park, high tech Zone, Jining City, Shandong Province Applicant before: Shandong kesidamei Biotechnology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210618 |
|
RJ01 | Rejection of invention patent application after publication |